Cited by 49

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Elimination of the Class A Scavenger Receptor Does Not Affect Amyloid Plaque Formation or Neurodegeneration in Transgenic Mice Expressing Human Amyloid Protein Precursors

Huang, Frederick, Buttini, Manuel, Wyss-Coray, Tony, McConlogue, Lisa, Kodama, Tatsuhiko, Pitas, Robert E., Mucke, Lennart·1999·The American Journal of Pathology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0002-9440(10)65489-2

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 38

  1. Hay, 1997, The costs and social burdens of Alzheimer disease: what can and should be done?, Alzheimer Dis Assoc Disord, 11, 181
  2. Ernst, 1997, Economic research on Alzheimer disease: a review of the literature, Alzheimer Dis Assoc Disord, 11, 135
  3. Masliah, 1996, Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease, J Neurosci, 16, 5795, 10.1523/JNEUROSCI.16-18-05795.1996 · DOI
  4. Hsiao, 1996, Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice, Science, 274, 99, 10.1126/science.274.5284.99 · DOI · Paper page
  5. Goldstein, 1979, Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition, Proc Natl Acad Sci USA, 76, 333, 10.1073/pnas.76.1.333 · DOI
  6. Krieger, 1994, Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP), Annu Rev Biochem, 63, 601, 10.1146/annurev.bi.63.070194.003125 · DOI
  7. Krieger, 1993, Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors, J Biol Chem, 268, 4569, 10.1016/S0021-9258(18)53430-X · DOI
  8. Younkin, 1995, Evidence that Aβ42 is the real culprit in Alzheimer's disease, Ann Neurol, 37, 287, 10.1002/ana.410370303 · DOI
  9. Lendon, 1997, Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population, Neurosci Lett, 222, 187, 10.1016/S0304-3940(97)13381-X · DOI
  10. Christie, 1996, Expression of the macrophage scavenger receptor, a multifunctional lipoprotein receptor, in microglia associated with senile plaques in Alzheimer's disease, Am J Pathol, 148, 399
  11. Paresce, 1996, Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor, Neuron, 17, 553, 10.1016/S0896-6273(00)80187-7 · DOI · Paper page
  12. Giulian, 1995, Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain, Neurochem Int, 27, 119, 10.1016/0197-0186(95)00067-I · DOI · Paper page
  13. Rockenstein, 1995, Levels and alternative splicing of amyloid β protein precursor (APP) transcripts in brains of transgenic mice and humans with Alzheimer's disease, J Biol Chem, 270, 28257, 10.1074/jbc.270.47.28257 · DOI
  14. Murrell, 1991, A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease, Science, 254, 97, 10.1126/science.1925564 · DOI
  15. Suzuki, 1997, A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection, Nature, 386, 292, 10.1038/386292a0 · DOI
  16. Masliah, 1992, Spectrum of human immunodeficiency virus-associated neocortical damage, Ann Neurol, 32, 321, 10.1002/ana.410320304 · DOI
  17. Bartoo, 1997, The mean Aβ load in the hippocampus correlates with duration and severity of dementia in subgroups of Alzheimer disease, J Neuropathol Exp Neurol, 56, 531, 10.1097/00005072-199705000-00009 · DOI
  18. Toggas, 1994, Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice, Nature, 367, 188, 10.1038/367188a0 · DOI
  19. Johnson-Wood, 1997, Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease, Proc Natl Acad Sci USA, 94, 1550, 10.1073/pnas.94.4.1550 · DOI
  20. Terry, 1991, Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment, Ann Neurol, 30, 572, 10.1002/ana.410300410 · DOI · Paper page
  21. Zhan, 1993, Quantitative assessment of the synaptophysin immuno-reactivity of the cortical neuropil in various neurodegenerative disorders with dementia, Dementia, 4, 66
  22. Dickson, 1995, Correlations of synaptic and pathological markers with cognition of the elderly, Neurobiol Aging, 16, 285, 10.1016/0197-4580(95)00013-5 · DOI · Paper page
  23. Buttini, 1999, Expression of human apolipoprotein E3 or E4 in the brains of Apoe−/− mice: isoform-specific effects on neurodegeneration, J Neurosci, 19, 4867, 10.1523/JNEUROSCI.19-12-04867.1999 · DOI
  24. Masliah, 1991, Cortical and subcortical patterns of synaptophysin-like immunoreactivity in Alzheimer's disease, Am J Pathol, 138, 235
  25. Knowles, 1998, Aβ associated neuropil changes: correlation with neuronal loss and dementia, J Neuropathol Exp Neurol, 57, 1122, 10.1097/00005072-199812000-00003 · DOI · Paper page
  26. Mucke, 1994, Synaptotrophic effects of human amyloid β protein precursor in the cortex of transgenic mice, Brain Res, 666, 151, 10.1016/0006-8993(94)90767-6 · DOI
  27. Brown, 1998, Neocortical synapse density and Braak stage in the Lewy body variant of Alzheimer disease: a comparison with classic Alzheimer disease and normal aging, J Neuropathol Exp Neurol, 57, 955, 10.1097/00005072-199810000-00007 · DOI
  28. Everall, 1997, Comparison of two quantitative methods for the evaluation of neuronal number in the frontal cortex in Alzheimer disease, J Neuropathol Exp Neurol, 56, 1202, 10.1097/00005072-199711000-00004 · DOI
  29. Wyss-Coray, 1997, Amyloidogenic role of cytokine TGF-β1 in transgenic mice and Alzheimer's disease, Nature, 389, 603, 10.1038/39321 · DOI · Paper page
  30. Pike, 1993, Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state, J Neurosci, 13, 1676, 10.1523/JNEUROSCI.13-04-01676.1993 · DOI · Paper page
  31. Lorenzo, 1994, β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red, Proc Natl Acad Sci USA, 91, 12243, 10.1073/pnas.91.25.12243 · DOI · Paper page
  32. Rabizadeh, 1994, Expression of the low-affinity nerve growth factor receptor enhances β-amyloid peptide toxicity, Proc Natl Acad Sci USA, 91, 10703, 10.1073/pnas.91.22.10703 · DOI
  33. Kounnas, 1995, LDL receptor-related protein, a multifunctional apoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation, Cell, 82, 331, 10.1016/0092-8674(95)90320-8 · DOI · Paper page
  34. Du, 1997, α2-Macroglobulin as a β-amyloid peptide-binding plasma protein, J Neurochem, 69, 299, 10.1046/j.1471-4159.1997.69010299.x · DOI · Paper page
  35. Hughes, 1998, α2-Macroglobulin associates with β-amyloid peptide and prevents fibril formation, Proc Natl Acad Sci USA, 95, 3275, 10.1073/pnas.95.6.3275 · DOI
  36. Narita, 1997, α2-Macroglobulin complexes with and mediates the endocytosis of β-amyloid peptide via cell surface low-density lipoprotein receptor-related protein, J Neurochem, 69, 1904, 10.1046/j.1471-4159.1997.69051904.x · DOI · Paper page
  37. Hecker, 1996, High and low annealing temperatures increase both specificity and yield in touchdown and stepdown PCR, Biotechniques, 20, 478, 10.2144/19962003478 · DOI
  38. Selkoe, 1997, Alzheimer's disease: genotypes, phenotypes, and treatments, Science, 275, 630, 10.1126/science.275.5300.630 · DOI

Cited by

Sorted by citations

Metadata

Authors
Huang, F., Buttini, M., Wyss-Coray, T., McConlogue, L., Kodama, T., Pitas, R. E., & Mucke, L.
Venue
The American Journal of Pathology
Publisher
Elsevier BV
Published
1999-11
Volume
155
Issue
5
Pages
1741-1747
ISSN
0002-9440
Cited by
49
References
10
Language
en
Funders
  • U.S. Public Health Service (AG11385)
  • Howard Hughes Medical Institute

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review